SET Senior Executive Vice President Manpong Senanarong said that SAFE will be listed and start trading on the SET in the Services industry group, Health Care Services sector.
SAFE provides comprehensive range of fertility services covering intracytoplasmic sperm injection (ICSI); egg, sperm and embryo freezing; preimplantation and non-invasive prenatal genetic testing; and genetics laboratory. The company has teams of embryologists and physicians with 22 years of experiences and applies advanced technologies that meet international standards. Consequently, the pregnancy rates at its centers are as high as 40-75 percent, staying ahead of the curve. The company is Thailand's first in vitro fertilization (IVF) clinic accredited by the Reproductive Technology Accreditation Committee (RTAC) of Australia and New Zealand. Today, the company operates five clinics in Bangkok and provinces with popular tourist destinations.
SAFE has a paid-up capital of THB 303.95 million with a par value of THB 1.00 each. The company allocated 76.75 million IPO shares, 23.95 million shares of which were newly issued shares and 52.8 million were existing common shares owned by Piccadilly Peak Limited. It offered 40.00 million shares to institutional investors, 23.16 million shares to persons at underwriters' discretion, 11.50 million shares to the company's and subsidiaries' patrons, and 2.09 million shares to the company's and subsidiaries' directors, executives and/or related persons and employees during October 25-27, 2023, at THB 21.00 each, raising a total of THB 502.90 million. OptAsia Capital Co., Ltd. is the financial adviser and Bualuang Securities pcl is the lead underwriter.
SAFE CEO Wiwat Quangkananurug said the listing will enable the company to grow its business and social impact as planned, and sharpen competitive edge to become a leader in fertility treatment, preimplantation and non-invasive prenatal genetic testing, and wellness in Asia. The proceeds arising from the fundraising will be used to invest in related business with potential, expand its branches and laboratory services to support the company group's growth, and as working capital.
SAFE's three major shareholders after the IPO are the Quangkananurug group (60.92 percent), North Haven Thai Private Equity Saturn Company (Hong Kong) Limited (which was registered by the Hong Kong law and has Morgan Stanley as a general partner) (12.50 percent) and Chanida Pattanotai (0.55 percent). The IPO price was based on book building. The company's dividend policy is to pay at least 50 percent of net profit from its separate financial statements after corporate income tax and legal reserves.
For more information on SAFE, please see the company's prospectus at the Securities and Exchange Commission's website at www.sec.or.th; and for general information, please visit www.safefertilitygroup.com and www.set.or.th.
Source: SET Corporate Communications